N-alkyltriazole compounds as LPAR antagonists
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of inflammatory diseases and disorders such as, for example, pulmonary fibrosis.
HOFFMAN-LA ROCHE INC.
C A A A C A
C07D A61P A61P A61P C07D A61P
inventional inventional inventional inventional inventional inventional
Achyutharao Matthew C. Yimin Matthew Michael Stephen Deems
Sidduri Lucas Qian Hamilton Gabriel